Insmed (INSM) Selling, General & Administrative (2010 - 2026)
Insmed's Selling, General & Administrative came in at $247.47 million for Q2 2026, up 59.9% from $154.76 million a year earlier and up 0.1% from the prior quarter.
Insmed (INSM) Selling, General & Administrative (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Insmed reported Selling, General & Administrative of $893.59 million, up 58.5% year-over-year; for FY2025, it came in at $701.17 million, up 52.1% from FY2024.
- Selling, General & Administrative has increased in each of the last five years, with a five-year compound annual growth rate of 28.1% (FY2020 to FY2025).
- Going back by year, Selling, General & Administrative was $461.12 million in FY2024 (+33.9%), $344.5 million in FY2023 (+29.6%), $265.78 million in FY2022 (+13.5%) and $234.27 million in FY2021 (+15.1%).
- The Q2 2026 figure represents the highest quarterly Selling, General & Administrative in data going back to Q2 2010.
- Year-over-year, Selling, General & Administrative has increased for 23 consecutive quarters, with growth averaging 53.4% over the last eight quarters.
- The year-over-year growth in Selling, General & Administrative has ranged between 4.9% (Q2 2022) and 67.6% (Q1 2026) over the last five years.
- Business Quant data shows INSM's Selling, General & Administrative at $247.26 million (Q1 2026), $212.48 million (Q4 2025) and $186.38 million (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Insmed | 24.26 Bn | 18.76 Bn | 358.27 Mn | 247.47 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 247.47 Mn |
| Mar 31, 2026 | 247.26 Mn |
| Dec 31, 2025 | 212.48 Mn |
| Sep 30, 2025 | 186.38 Mn |
| Jun 30, 2025 | 154.76 Mn |
| Mar 31, 2025 | 147.55 Mn |
| Dec 31, 2024 | 142.52 Mn |
| Sep 30, 2024 | 118.93 Mn |
| Jun 30, 2024 | 106.57 Mn |
| Mar 31, 2024 | 93.10 Mn |
| Dec 31, 2023 | 89.53 Mn |
| Sep 30, 2023 | 90.63 Mn |
| Jun 30, 2023 | 84.43 Mn |
| Mar 31, 2023 | 79.91 Mn |
| Dec 31, 2022 | 73.48 Mn |
| Sep 30, 2022 | 75.58 Mn |
| Jun 30, 2022 | 59.97 Mn |
| Mar 31, 2022 | 56.75 Mn |
| Dec 31, 2021 | 65.27 Mn |
| Sep 30, 2021 | 60.28 Mn |
Insmed Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=INSM&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "INSM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=INSM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();